The Latest Breaking News from Medicare

The healthcare industry thrives due to novel drug pipeline discoveries, AI integration to streamline processes and technological advancements. So, investing in undervalued healthcare stocks with upside potential, Pfizer (PFE), Cigna Group (CI), and Centene Corp (CNC), could be a wise idea. Keep reading….

Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics warn it may hinder patient access and innovation.

‘Abrupt’ announcement will affect many women who have been planning their conception journeys to begin in early 2025, provider says

Trump is talking about cutting government spending, but that's mostly in Congress' hands.

Medicare Advantage plans are evolving, and 2025 is shaping up to bring significant improvements and opportunities for enrollees. But what exactly is changing? What updates should you know about to make informed decisions regarding your healthcare? ...

Economists answer 10 pressing questions about the US economy, including why food is still expensive and why there hasn't been a recession.

Dr. Mehmet Oz, President-elect Donald Trump's pick to lead the Centers for Medicare and Medicaid Services, was mocked for peddling supplements ahead of the holidays.

Donald Trump's health team picks includes outspoken critics of the medical establishment and COVID-19 health measures

Maximus announces CMS has canceled the early re-procurement of its Medicare contract, allowing the company to continue its current work until 2031.